Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000245207

Medchemexpress LLC Talniflumate | 66898-62-2 | MFCD00866135 | 99.7% | 414.33 g/mol | C21H13F3N2O4 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1033705MG

Encompass_Preferred

Talniflumate is a research chemical prodrug of niflumic acid that is converted in vivo by esterases and acts as an orally active Ca2+-activated chloride channel (CaCC) blocker with reported analgesic and anti-inflammatory effects in preclinical models.

  • Prodrug of niflumic acid converted by esterases in vivo.
  • Orally active Ca2+-activated chloride channel (CaCC) blocker.
  • Suitable for in vitro and in vivo preclinical studies.
  • Powder form with recommended storage at -20°C for long-term stability.
  • Soluble in DMSO (≈62.5 mg/mL) and formulatable for in vivo dosing.

Catalog No. 50-002-45207


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.